DAFNA Capital Management LLC - Q1 2022 holdings

$384 Million is the total value of DAFNA Capital Management LLC's 94 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 17.2% .

 Value Shares↓ Weighting
STXS  STEREOTAXIS INC$51,028,000
-39.8%
13,680,5540.0%13.30%
-37.7%
XBI NewSPDR SP BIOTECH ETFetf$24,223,000269,500
+100.0%
6.31%
FATE BuyFATE THERAPEUTICS INC$19,421,000
-10.8%
500,930
+34.6%
5.06%
-7.6%
BPMC BuyBLUEPRINT MEDICINES CORP$15,732,000
-29.0%
246,280
+19.0%
4.10%
-26.4%
ACET SellADICET BIO INC$14,296,000
+11.5%
715,872
-2.4%
3.72%
+15.5%
IBB BuyISHARES TR NASDAQ BIOTECH INDXetf$13,356,000
+114.0%
102,500
+150.6%
3.48%
+121.7%
XENE SellXENON PHARMACEUTICALS INC$11,622,000
-7.6%
380,163
-5.6%
3.03%
-4.3%
KRTX BuyKARUNA THERAPEUTICS INC$10,403,000
+9.7%
82,053
+13.3%
2.71%
+13.6%
DXCM  DEXCOM INC$9,279,000
-4.7%
18,1380.0%2.42%
-1.3%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$9,201,000
+14.9%
77,600
+33.6%
2.40%
+19.1%
NBIX  NEUROCRINE BIOSCIENCES INC$7,843,000
+10.1%
83,6550.0%2.04%
+14.1%
CYTK BuyCYTOKINETICS INC$7,785,000
+27.4%
211,495
+57.7%
2.03%
+32.0%
NRIX BuyNURIX THERAPEUTICS INC$7,612,000
-14.2%
543,344
+77.4%
1.98%
-11.1%
MORF  MORPHIC HLDG INC$7,286,000
-15.3%
181,4670.0%1.90%
-12.2%
CSII  CARDIOVASCULAR SYS INC$6,486,000
+20.3%
286,9880.0%1.69%
+24.7%
SNDX BuySYNDAX PHARMACEUTICALS INC$6,465,000
-0.4%
371,987
+25.4%
1.68%
+3.2%
MRUS BuyMERUS N V$6,213,000
-13.6%
234,989
+3.9%
1.62%
-10.5%
SAGE  SAGE THERAPEUTICS INC$5,968,000
-22.2%
180,3060.0%1.56%
-19.4%
RVMD BuyREVOLUTION MEDICINES INC$5,921,000
+10.8%
232,101
+9.4%
1.54%
+14.9%
IDYA BuyIDEAYA BIOSCIENCES INC$5,484,000
-49.6%
490,061
+6.5%
1.43%
-47.8%
CBAY SellCYMABAY THERAPEUTICS INC$5,264,000
-12.9%
1,692,569
-5.3%
1.37%
-9.7%
ISEE BuyIVERIC BIO INC$5,023,000
+8.9%
298,476
+8.2%
1.31%
+12.8%
NTUS  NATUS MEDICAL INC$5,010,000
+10.7%
190,6350.0%1.30%
+14.7%
APLS NewAPELLIS PHARMACEUTICALS INC$4,773,00093,935
+100.0%
1.24%
ATRC  ATRICURE INC$4,730,000
-5.6%
72,0290.0%1.23%
-2.1%
RCUS BuyARCUS BIOSCIENCES INC$4,583,000
-3.4%
145,217
+23.9%
1.19%
+0.1%
ALEC BuyALECTOR INC$4,172,000
+30.1%
292,747
+88.6%
1.09%
+34.9%
 RADIUS HEALTH INCnote 3.000% 9/0$3,891,000
+0.8%
4,000,0000.0%1.01%
+4.4%
ASND BuyASCENDIS PHARMA A/Ssponsored adr$3,593,000
+142.8%
30,612
+178.3%
0.94%
+151.6%
OTIC SellOTONOMY INC$3,594,000
-21.5%
1,497,514
-31.9%
0.94%
-18.7%
MRTX NewMIRATI THERAPEUTICS INC$3,511,00042,700
+100.0%
0.92%
EWTX NewEDGEWISE THERAPEUTICS INC$3,460,000356,750
+100.0%
0.90%
IPSC BuyCENTURY THERAPEUTICS INC$3,234,000
+103.7%
256,892
+156.5%
0.84%
+111.3%
ARAY  ACCURAY INC$3,117,000
-30.6%
941,8000.0%0.81%
-28.1%
BuyPARDES BIOSCIENCES INC$3,041,000
-20.4%
421,157
+80.4%
0.79%
-17.6%
BuyFIELD TRIP HEALTH LTD$2,936,000
+249.9%
2,191,308
+542.8%
0.76%
+262.6%
ITOS BuyITEOS THERAPEUTICS INC$2,874,000
+14.1%
89,298
+65.1%
0.75%
+18.3%
KALV  KALVISTA PHARMACEUTICALS INC$2,810,000
+11.4%
190,6630.0%0.73%
+15.5%
RIGL BuyRIGEL PHARMACEUTICALS INC$2,679,000
+15.0%
896,100
+1.9%
0.70%
+19.1%
GLPG  GALAPAGOS NVspon adr$2,647,000
+12.5%
42,6750.0%0.69%
+16.6%
AXGN  AXOGEN INC$2,637,000
-15.3%
332,1030.0%0.69%
-12.3%
AERI  AERIE PHARMACEUTICALS INC$2,630,000
+29.6%
289,0400.0%0.68%
+34.3%
AFMD  AFFIMED N V$2,497,000
-20.8%
571,2820.0%0.65%
-17.9%
FSTX  F-STAR THERAPEUTICS INC$2,463,000
-29.3%
693,7850.0%0.64%
-26.7%
BCYC NewBICYCLE THERAPEUTICS PLCsponsored ads$2,334,00053,200
+100.0%
0.61%
ATHA  ATHIRA PHARMA INC$2,173,000
+3.6%
160,9830.0%0.57%
+7.2%
AUTL NewAUTOLUS THERAPEUTICS PLCspon ads$2,069,000496,150
+100.0%
0.54%
SURF BuySURFACE ONCOLOGY INC$1,999,000
+32.7%
680,000
+115.9%
0.52%
+37.5%
KURA BuyKURA ONCOLOGY INC$1,822,000
+17.4%
113,329
+2.3%
0.48%
+21.8%
NewDICE THERAPEUTICS INC$1,798,00094,000
+100.0%
0.47%
BWAY  BRAINSWAY LTDsponsored ads$1,746,000
+13.4%
200,0000.0%0.46%
+17.6%
BMEA BuyBIOMEA FUSION INC$1,712,000
-26.8%
383,923
+22.3%
0.45%
-24.1%
RDUS  RADIUS HEALTH INC$1,695,000
+27.6%
191,9780.0%0.44%
+32.3%
MGNX BuyMACROGENICS INC$1,692,000
+17.1%
192,000
+113.3%
0.44%
+21.5%
COGT  COGENT BIOSCIENCES INC$1,674,000
-12.7%
223,5540.0%0.44%
-9.5%
KNTE BuyKINNATE BIOPHARMA INC$1,668,000
-11.6%
148,151
+39.2%
0.44%
-8.2%
RGLS  REGULUS THERAPEUTICS INC$1,656,000
-5.4%
5,555,5550.0%0.43%
-1.8%
NGM BuyNGM BIOPHARMACEUTICALS INC$1,642,000
+15.2%
107,653
+33.8%
0.43%
+19.6%
IMCR NewIMMUNOCORE HOLDINGS PLCads$1,611,00053,878
+100.0%
0.42%
TPTX BuyTURNING POINT THERAPEUTICS I$1,596,000
-28.0%
59,452
+28.0%
0.42%
-25.3%
MRSN BuyMERSANA THERAPEUTICS INC$1,408,000
+61.5%
352,763
+151.5%
0.37%
+67.6%
VERO SellVENUS CONCEPT INC$1,385,000
-16.5%
968,187
-0.8%
0.36%
-13.4%
MREO BuyMEREO BIOPHARMA GROUP PLCads$1,363,000
-24.4%
1,216,613
+8.0%
0.36%
-21.6%
 AERIE PHARMACEUTICALS INCnote 1.500%10/0$1,345,000
+8.2%
1,500,0000.0%0.35%
+11.8%
VKTX  VIKING THERAPEUTICS INC$1,342,000
-34.8%
447,4000.0%0.35%
-32.4%
ETNB Buy89BIO INC$1,222,000
-35.4%
324,053
+124.0%
0.32%
-33.2%
MEIP BuyMEI PHARMA INC$1,065,000
-77.4%
1,767,146
+0.1%
0.28%
-76.5%
GHRS NewGH RESEARCH PLCordinary shares$1,006,00055,000
+100.0%
0.26%
CMPS NewCOMPASS PATHWAYS PLCsponsored ads$965,00074,890
+100.0%
0.25%
STIM  NEURONETICS INC$951,000
-32.0%
313,7170.0%0.25%
-29.5%
SellTHESEUS PHARMACEUTICALS INC$924,000
-25.2%
80,124
-17.8%
0.24%
-22.5%
NXTC  NEXTCURE INC$912,000
-19.0%
187,6960.0%0.24%
-15.9%
BDTX BuyBLACK DIAMOND THERAPEUTICS I$869,000
-20.9%
313,600
+52.2%
0.23%
-18.1%
WVE  WAVE LIFE SCIENCES LTD$780,000
-36.3%
390,1610.0%0.20%
-34.1%
GNFT BuyGENFIT S Aads$752,000
+149.0%
187,940
+210.9%
0.20%
+157.9%
ADAP BuyADAPTIMMUNE THERAPEUTICS PLCsponds adr$723,000
+41.5%
351,064
+157.6%
0.19%
+46.9%
NewVIGIL NEUROSCIENCE INC$701,00099,754
+100.0%
0.18%
STRO BuySUTRO BIOPHARMA INC$696,000
+3.9%
84,700
+88.2%
0.18%
+7.7%
PHVS SellPHARVARIS N V$628,000
+18.9%
34,615
-5.7%
0.16%
+23.3%
LVTX  LAVA THERAPEUTICS NV$613,000
-20.0%
139,3320.0%0.16%
-17.1%
HARP  HARPOON THERAPEUTICS INC$523,000
-34.1%
105,1630.0%0.14%
-32.0%
PHAS  PHASEBIO PHARMACEUTICALS INC$500,000
-49.4%
378,6110.0%0.13%
-47.6%
INGN  INOGEN INC$486,000
-4.7%
15,0000.0%0.13%
-0.8%
SCYX  SCYNEXIS INC$474,000
-35.9%
121,2420.0%0.12%
-33.3%
MASI  MASIMO CORP$437,000
-50.2%
3,0000.0%0.11%
-48.4%
CGEN SellCOMPUGEN LTDord$419,000
-51.6%
130,202
-35.4%
0.11%
-50.0%
MDGL SellMADRIGAL PHARMACEUTICALS INC$304,000
-36.0%
3,100
-44.6%
0.08%
-33.6%
CMPX  COMPASS THERAPEUTICS INC$269,000
-56.8%
196,0910.0%0.07%
-55.1%
ASLN SellASLAN PHARMACEUTICALS LTDads$219,000
-73.3%
243,720
-66.7%
0.06%
-72.3%
LCTX BuyLINEAGE CELL THERAPEUTICS IN$216,000
+10.2%
140,000
+75.0%
0.06%
+14.3%
LRMR SellLARIMAR THERAPEUTICS INC$202,000
-73.3%
49,996
-28.8%
0.05%
-72.1%
SRGA  SURGALIGN HOLDINGS INC$176,000
-57.6%
579,7100.0%0.05%
-55.8%
INFI SellINFINITY PHARMACEUTICALS INC$137,000
-74.2%
120,097
-49.1%
0.04%
-73.1%
ANNX  ANNEXON INC$84,000
-76.3%
30,7960.0%0.02%
-75.3%
BOLT ExitBOLT BIOTHERAPEUTICS INC$0-100,000
-100.0%
-0.12%
PRQR ExitPROQR THERAPEUTICS N V$0-85,476
-100.0%
-0.17%
HOOK ExitHOOKIPA PHARMA INC$0-320,444
-100.0%
-0.19%
ARNA ExitARENA PHARMACEUTICALS INC$0-119,615
-100.0%
-2.80%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STEREOTAXIS INC42Q3 202327.6%
ATRICURE INC42Q3 202311.4%
MASIMO CORPORATION42Q3 20231.8%
ASCENDIS PHARMA A S SPONSORED34Q3 20234.5%
AERIE PHARMACEUTICALS INC33Q3 20224.2%
GALAPAGOS NV-SPON ADR33Q3 20233.8%
XENON PHARMACEUTICALS INC33Q3 20233.6%
NEUROCRINE BIOSCIENCES INC32Q3 20232.9%
JOHNSON AND JOHNSON32Q1 20211.2%
ISHARES TR NASDQ BIOTECH30Q3 20234.0%

View DAFNA Capital Management LLC's complete holdings history.

Latest significant ownerships (13-D/G)
DAFNA Capital Management LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Stereotaxis, Inc.March 08, 201813,680,55423.4%
SUNESIS PHARMACEUTICALS INCFebruary 14, 2018983,0002.9%
SUNESIS PHARMACEUTICALS INCFebruary 14, 20171,133,5835.4%
WINDTREE THERAPEUTICS INC /DE/February 14, 2017208,3332.4%
ANAVEX LIFE SCIENCES CORP.Sold outFebruary 16, 201600.0%
DISCOVERY LABORATORIES INC /DE/February 16, 201610,658,6999.2%
PRECISION OPTICS CORPORATION, INC.February 13, 2015311,5375.0%
TearLab CorpFebruary 14, 2013939,2393.2%
VIKING SYSTEMS INCFebruary 14, 20123,781,4685.2%

View DAFNA Capital Management LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15

View DAFNA Capital Management LLC's complete filings history.

Compare quarters

Export DAFNA Capital Management LLC's holdings